CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Millennium Pharmaceuticals Inc. v. Fresenius Kabi USA LLC

1:13-cv-00467

Overview

Case Number 1:13-cv-00467
Filing Date 2013-03-22
Status Terminated
Termination Date 2014-04-14
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Plaintiff

Millennium Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Fresenius Kabi Pharmaceuticals Holding Inc. Operating Company

Represented By

2 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Fresenius Kabi USA Inc. Operating Company

Represented By

2 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Fresenius Kabi USA LLC Operating Company

Represented By

6 Attorneys Listed

Jonathan A. Auerbach

UNDELIVERABLE EMAIL 9/28/2016

John Hanish

Email: jhanish@maynardcooper.com

Jessica H. Zafonte

Email: jzafonte@haugpartners.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Daryl L. Wiesen

Email: dwiesen@goodwinlaw.com

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 9 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (9 found):
U.S. Courts: 9
U.S. District Court 2017-04-13
1:17-cv-00423

Millennium Pharmaceuticals, Inc. v. Zydus Pharmaceuticals (USA) Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-04-13
1:17-cv-00422

Millennium Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2016-04-04
1:16-cv-00223

Millennium Pharmaceuticals Inc. v. Actavis LLC

Asserted Patent
Status: DED
U.S. District Court 2015-09-10
1:15-cv-00804

Millennium Pharmaceuticals Inc. v. Hospira, Inc.

Asserted Patent
Status: DED
U.S. District Court 2015-06-25
1:15-cv-00540

Millennium Pharmaceuticals Inc. v. Sun Pharmaceutical Industries Limited

Asserted Patent
Status: DED
U.S. District Court 2015-01-14
1:15-cv-00039

Millennium Pharmaceuticals Inc. v. Hetero Labs Limited

Asserted Patent
Status: DED
U.S. District Court 2015-01-14
1:15-cv-00040

Millennium Pharmaceuticals Inc. v. Mylan Laboratories Limited

Asserted Patent
Status: DED
U.S. District Court 2014-01-22
1:14-cv-00093

Millennium Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2012-12-21
1:12-cv-01750

Millennium Pharmaceuticals Inc. v. Actavis Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6713446
Formulation of boronic acid compounds
Filed: 2002-01-25
Issued: 2004-03-30
Expired (Term Ended)
Expires: 2022-01-25
US6958319
Formulation of boronic acid compounds
Filed: 2003-09-18
Issued: 2005-10-25
Expired (Term Ended)
Expires: 2022-04-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

0

Granted

0

Denied

0

Pending / Review

6

Motions by Category

Claim Construction / Markman Filing 5 Procedural / Extension Motion 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Exchange (1) Opening Expert Reports, (2) Rebuttal Expert Reports, (3) Reply Expert Reports to April 7, 2014; May 19, 2014; June 9,...
Entry #58 • 2014-03-20 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION ANSWERING BRIEF re 29 Claim Construction Opening Brief filed by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Additional attachment(...
Entry #34 • 2013-09-30 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION ANSWERING BRIEF re 28 Claim Construction Opening Brief Defendants' Answering Claim Construction Brief filed by Fresenius Kabi Pharmaceuticals...
Entry #36 • 2013-09-30 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION OPENING BRIEF filed by Millennium Pharmaceuticals Inc.. (Attachments: # 1 Exhibits A through C)(Noreika, Maryellen) (Entered: 08/30/2013)
Entry #28 • 2013-08-30 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION OPENING BRIEF Defendants' Opening Claim Construction Brief filed by Fresenius Kabi Pharmaceuticals Holding Inc., Fresenius Kabi USA Inc., Fre...
Entry #29 • 2013-08-30 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM Construction Chart by Fresenius Kabi Pharmaceuticals Holding Inc., Fresenius Kabi USA Inc., Fresenius Kabi USA LLC, Millennium Pharmaceuticals Inc., Accor...
Entry #25 • 2013-08-09 Document →

Docket Entries

(65 total)
Pleading / Complaint

COMPLAINT filed against Fresenius Kabi Pharmaceuticals Holding Inc., Fresenius Kabi USA Inc., Fresenius Kabi USA LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1254891.) - filed by Millennium Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(els) (Entered: 03/25/2013)

Entry #1 • 2013-03-22
1
Pleading / Complaint

COMPLAINT filed against Fresenius Kabi Pharmaceuticals Holding Inc., Fresenius Kabi USA Inc., Fresenius Kabi USA LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1254891.) - filed by Millennium Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(els) (Entered: 03/25/2013)

Entry #1 • 2013-03-22
2
Pleading / Complaint

COMPLAINT filed against Fresenius Kabi Pharmaceuticals Holding Inc., Fresenius Kabi USA Inc., Fresenius Kabi USA LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1254891.) - filed by Millennium Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(els) (Entered: 03/25/2013)

Entry #1 • 2013-03-22
2
Pleading / Complaint

COMPLAINT filed against Fresenius Kabi Pharmaceuticals Holding Inc., Fresenius Kabi USA Inc., Fresenius Kabi USA LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1254891.) - filed by Millennium Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(els) (Entered: 03/25/2013)

Entry #1 • 2013-03-22
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (els) (Entered: 03/25/2013)

Entry #2 • 2013-03-22
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc